新加止嗽散治疗咳嗽变异性哮喘30例临床观察

Clinical Observation of Using Xinjia Zhisou Powder in the Treatment of Cough Variant Asthma

目的:观察止嗽散化裁对咳嗽变异性哮喘(CVA)的临床疗效。方法:将60例咳嗽变异性哮喘患者随机分为观察组和对照组各30例,观察组予新加止嗽散治疗,对照组予依替米星注射液和沙美特罗替卡松粉吸入剂联合治疗,观察两组患者咳嗽、咯痰等症状的缓解情况。结果:观察组显效23例,有效5例,无效2例,总有效率93.33%;对照组显效14例,有效8例,无效8例,总有效率73.33%,两组比较差别有统计学意义(P<0.05)。结论:新加止嗽散治疗咳嗽变异性哮喘疗效显著,值得临床推广应用。

Objective：To observe the clinical curative efficacy of cough variant asthma treated by Zhisou Powder.Methods：60 patients who were diagnosed as CVA were randomly divided into controlled group and treatment group.The treatment group was treated with Zhisou Powder.The controlled group was treated with etimicin sulfate for injection and salmeterol and fluticasone propionate inhaler.Observing the treatment efficacy in these two groups.Results：The total effective rate of the treatment group was 93.33%,which was higher than the controlled group（73.33%）,and the difference was significant（P〈0.05）.Conclusion：Xinjia Zhisou Powder has a good effect on patients with CVA and it is worthy of clinical promotion.